Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Diseases

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies

Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

NCT06942949

Conditions: Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Arizona State Urological Research Institute Phoenix, Arizona, United States

Arkansas Urology Research Center Little Rock, Arkansas, United States

Michael G. Oefelein Clinical Trials Bakersfield, California, United States

San Diego Clinical Trials La Mesa, California, United States

View all 20 locations

View Trial Details

Recruiting

Suprapubic Drainage During Transurethral Cystolithotripsy for Large Bladder Stones

NCT07642440

Conditions: Bladder Stone, Calculi, Cystolithiasis, +11 more
Locations: Department of Urology- Beni-Suef University Hospitals Banī Suwayf, Beni Suweif Governorate, Egypt

View Trial Details

Recruiting

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

NCT07524101

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
Locations: Severance Hospital Seoul, South Korea

View Trial Details

Recruiting

Spinal Versus General Anesthesia in Open Simple Prostatectomy

NCT07643415

Conditions: Anesthesia, Benign Prostatic Hyperplasia, Female Urogenital Diseases, +17 more
Locations: Hitit university Çorum, Turkey (Türkiye)

hitit Üniversity Çorum, Turkey (Türkiye)

View Trial Details

Recruiting

Investigation of Lymph Node Biology in Kidney Cancer

NCT07038733

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1

NCT06030843

Conditions: Cardio-Renal Syndrome, Cardiovascular Diseases, Empagliflozin in Cardiorenal Syndrome Type 1, +9 more
Locations: Faculty of Medicine, Chulalongkorn University Bangkok, Pathumwan, Thailand

View Trial Details

Recruiting

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

NCT07559396

Conditions: Chronic Disease, Disease Attributes, Female Urogenital Diseases, +11 more
Locations: Floridian Clinical Research Miami Lakes, Florida, United States

Orlando Clinical Research Center Orlando, Florida, United States

View Trial Details

Recruiting

"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"

NCT07417969

Conditions: Edema, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: 76000 Querétaro City, Querétaro, Mexico

View Trial Details

Recruiting

Akyva First In Human

NCT06956209

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Australian Prostate Centre Melbourne N., Victoria, Australia

View Trial Details

Recruiting

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT05797610

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Alabama Kidney Research - ERN - PPDS Alabaster, Alabama, United States

UAB Nephrology Research Clinic Birmingham, Alabama, United States

Sunrise Medical Management LLC Surprise, Arizona, United States

Tucson Neuroscience Research - M3 WR Tucson, Arizona, United States

View all 204 locations

View Trial Details